MedTrace Logo

Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care

NCT02499679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4737

Last updated 2025-07-30

Study results available
· View outcomes & findings →

Summary

The objective of the HeartFlow ADVANCE Registry is to evaluate utility, clinical outcomes and resource utilization of FFRCT-guided evaluation in clinically stable, symptomatic patients with coronary artery disease (CAD) in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis and management of CAD.

Conditions

Sponsors & Collaborators

  • HeartFlow, Inc.

    lead INDUSTRY

Principal Investigators

  • Manesh Patel, MD · Duke Health

  • Jonathon Leipsic, MD · Providence Health & Services

  • Koen Nieman, MD · Erasmus Medical Center

  • Takashi Akasaka, MD · Wakayama Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2019-02-28
Completion
2019-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02499679 on ClinicalTrials.gov